Potential lipase inhibitors from Chinese medicinal herbs

References

• Birari RB, Bhutani KK. 2007. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 12:879–889.
   PubMed Web of Science ®Google Scholar
• Cheung BM, Cheung TT, Samaranayake NR. 2013. Safety of antiobesity drugs. Ther Adv Drug Saf. 4:171–181.
   PubMedGoogle Scholar
• Cicero AF, Vitale G, Savino G, Arletti R. 2003. Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res. 17:174–178.
   PubMed Web of Science ®Google Scholar
• de la Garza AL, Milagro FI, Boque N, Campión J, Martínez JA. 2011. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Med. 77:773–785.
   PubMed Web of Science ®Google Scholar
• Deng X, Jiang M, Zhao X, Liang J. 2014. Efficacy and safety of traditional Chinese medicine for the treatment of acquired immunodeficiency syndrome: a systematic review. J Tradit Chin Med. 34:1–9.
   PubMed Web of Science ®Google Scholar
• Hadvary P, Lengsfeld H, Wolfer H. 1988. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J. 256:357–361.
   PubMed Web of Science ®Google Scholar
• Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. 2002. Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice. J Nutr. 132:2241–2245.
   PubMed Web of Science ®Google Scholar
• Han LK, Zheng YN, Yoshikawa M, Okuda H, Kimura Y. 2005. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med. 5:9.
   PubMedGoogle Scholar
• Hill JO, Melanson EL, Wyatt HT. 2000. Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr. 130:284S–288S.
   PubMed Web of Science ®Google Scholar
• Hwang JT, Lee MS, Kim HJ, Sung MJ, Kim HY, Kim MS, Kwon DY. 2009. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res. 23:262–266.
   PubMed Web of Science ®Google Scholar
• Jung RT. 1997. Obesity as a disease. Br Med Bull. 53:307–321.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kang MH. 2005. Screening of Korean medicinal plants for lipase inhibitory activity. Phytother Res. 19:359–361.
   PubMed Web of Science ®Google Scholar
• Kim IW, Sun WS, Yun BS, Kim NR, Min D, Kim SK. 2013. Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials. J Ginseng Res. 37:124–134.
   PubMed Web of Science ®Google Scholar
• Kim SH, Park KS. 2003. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res. 48:511–513.
   PubMed Web of Science ®Google Scholar
• Kopelman PG. 2000. Obesity as a medical problem. Nature. 404:635–643.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. 2011. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 130:157–176.
   PubMed Web of Science ®Google Scholar
• Lee YP, Chung GH, Rhee JS. 1993. Purification and characterization of Pseudomonas fluorescens SIK W1 lipase expressed in Escherichia coli. Biochim Biophys Acta. 1169:156–164.
   PubMed Web of Science ®Google Scholar
• Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König HH. 2013. Economic costs of overweight and obesity. Best Pract Res Clin Endocrinol Metab. 27:105–115.
   PubMed Web of Science ®Google Scholar
• Leung WY, Thomas GN, Chan JC, Tomlinson B. 2003. Weight management and current options in pharmacotherapy: orlistat and sibutramine. Clin Ther. 25:58–80.
   PubMed Web of Science ®Google Scholar
• Li F, Li W, Fu H, Zhang Q, Koike K. 2007. Pancreatic lipase-inhibiting triterpenoid saponins from fruits of Acanthopanax senticosus. Chem Pharm Bull (Tokyo). 55:1087–1089.
   PubMed Web of Science ®Google Scholar
• Molinari G. 2009. Natural products in drug discovery: present status and perspectives. Adv Exp Med Biol. 655:13–27.
   PubMed Web of Science ®Google Scholar
• Mora T, Gil J, Sicras-Mainar A. 2015. The influence of obesity and overweight on medical costs: a panel data perspective. Eur J Health Econ. 16:161–173.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 70:461–477.
   PubMed Web of Science ®Google Scholar
• Ramirez G, Zavala M, Perez J, Zamilpa A. 2012. In vitro screening of medicinal plants used in Mexico as antidiabetics with glucosidase and lipase inhibitory activities. Evid Based Complement Alternat Med. 2012:701261.
   PubMed Web of Science ®Google Scholar
• Roh C, Jung U. 2012. Screening of crude plant extracts with anti-obesity activity. Int J Mol Sci. 13:1710–1719.
   PubMed Web of Science ®Google Scholar
• Sharma N, Sharma VK, Seo SY. 2005. Screening of some medicinal plants for anti-lipase activity. J Ethnopharmacol. 97:453–456.
   PubMed Web of Science ®Google Scholar
• Shi Y, Burn P. 2004. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov. 3:695–710.
   PubMed Web of Science ®Google Scholar
• Slanc P, Doljak B, Kreft S, Lunder M, Janes D, Strukelj B. 2009. Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition. Phytother Res. 23:874–877.
   PubMed Web of Science ®Google Scholar
• Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, et al. 2012. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. 10:22
   PubMed Web of Science ®Google Scholar
• Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ. 2008. Indirect costs of obesity: a review of the current literature. Obes Rev. 9:489–500.
   PubMed Web of Science ®Google Scholar
• Tsai WH, Yang CC, Li PC, Chen WC, Chien CT. 2013. Therapeutic potential of traditional chinese medicine on inflammatory diseases. J Tradit Complement Med. 3:142–151.
   PubMedGoogle Scholar
• Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. 2008. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 16:2323–2330.
   PubMed Web of Science ®Google Scholar
• Winkler UK, Stuckmann M. 1979. Glycogen, hyaluronate, and some other polysaccharides greatly enhance the formation of exolipase by Serratia marcescens. J Bacteriol. 138:663–670.
   PubMed Web of Science ®Google Scholar
• Xie W, Zhao Y, Du L. 2012. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia. J Ethnopharmacol. 140:345–367.
   PubMed Web of Science ®Google Scholar
• Yao H, Shi P, Shao Q, Fan X. 2011. Chemical fingerprinting and quantitative analysis of a Panax notoginseng preparation using HPLC-UV and HPLC-MS. Chin Med. 6:9.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen J, Jiang X, Wang J, Yan X, Zheng Y, Conklin DJ, Kim KS, Kim KH, Tan Y, et al. 2014. The magnolia bioactive constituent 4-O-methylhonokiol protects against high-fat diet-induced obesity and systemic insulin resistance in mice. Oxid Med Cell Longev. 2014:965954.
   PubMedGoogle Scholar
• Zheng CD, Duan YQ, Gao JM, Ruan ZG. 2010. Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs. J Chin Med Assoc. 73:319–324.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou T, Jiang M, Wang X, Liu Q, Zhan Z, Zhang X. 2014. Research progress on synergistic anti-tumor mechanisms of compounds in traditional Chinese medicine. J Tradit Chin Med. 34:100–105.
   PubMed Web of Science ®Google Scholar